000 01163 a2200325 4500
005 20250515174658.0
264 0 _c20100518
008 201005s 0 0 eng d
022 _a1471-4973
024 7 _a10.1016/j.coph.2009.05.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOhta, Akio
245 0 0 _aThe adenosinergic immunomodulatory drugs.
_h[electronic resource]
260 _bCurrent opinion in pharmacology
_cAug 2009
300 _a501-6 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdenosine
_xadverse effects
650 0 4 _aAdenosine A2 Receptor Antagonists
650 0 4 _aAnimals
650 0 4 _aCell Hypoxia
_xphysiology
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
650 0 4 _aInflammation
_xdrug therapy
650 0 4 _aReceptor, Adenosine A2A
_xadministration & dosage
650 0 4 _aReceptor, Adenosine A2B
_xphysiology
650 0 4 _aSignal Transduction
_xphysiology
700 1 _aSitkovsky, Michail
773 0 _tCurrent opinion in pharmacology
_gvol. 9
_gno. 4
_gp. 501-6
856 4 0 _uhttps://doi.org/10.1016/j.coph.2009.05.005
_zAvailable from publisher's website
999 _c18957715
_d18957715